Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
close

SKYRIZI - 75mg - 2+2alcohol pads

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L04AC18 BioTech Risankizumab - 75mg 10195 143719/1 SKYRIZI 75mg 2+2alcohol pads Injectable solution SC Interpharma S.A.L. Boehringer Ingelheim Pharma GmbH & Co KG Germany 4,534,779 L.L 2.44 E2 Abbvie Deutschland GmbH & Co KG Germany 2/5/2024

Drugs With Same Ingredients

ATC B/G Ingredients code Registration Nb Name Dosage Presentation Form Route Agent Laboratory Country Price Pharmacist Margin Stratum Responsible Party Name Responsible Party Country Exch_date %SUBSIDY
L04AC18 BioTech Risankizumab - 150mg 11112 103421/1 SKYRIZI 150mg 1 Injectable solution SC Interpharma S.A.L. Abbvie Biotechnology Ltd USA 4,534,779 L.L 2.44 E2 Abbvie Deutschland GmbH & Co KG Germany 2/5/2024
L04AC18 BioTech Risankizumab - 75mg 10195/945 143719/1 SKYRIZI 75mg 2+2alcohol pads Injectable solution SC Interpharma S.A.L. Boehringer Ingelheim Pharma GmbH & Co KG Germany 194,911,251 L.L 2.44 E2 Abbvie Deutschland GmbH & Co KG Germany 2/5/2024
L04AC18 BioTech Risankizumab - 150mg 11112/945 103421/1 SKYRIZI 150mg 1 Injectable solution SC Interpharma S.A.L. Abbvie Biotechnology Ltd USA 194,911,251 L.L 2.44 E2 Abbvie Deutschland GmbH & Co KG Germany 2/5/2024
Sitemap
© Copyrights reserved to Ministry of Public Health 2024